Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs

RTTNews | 266 days ago
Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs

(RTTNews) - Amgen, Inc. (AMGN) announced Monday the opening of its manufacturing site in Central Ohio, the newest in its global operations network and the most advanced facility to date.

The nearly 300,000-square-foot facility will employ 400 full-time staff. It also features open workspaces to foster collaboration and has been designed to meet the highest environmental sustainability standards, in support of Amgen's commitment to achieve carbon neutrality for all operations by 2027.

In partnership with Columbus State Community College, Amgen is hosting an inaugural 18-month manufacturing apprenticeship at the site. This program, designed for those new to the field or changing careers, offers a blend of classroom and practical training, aiming to expand opportunities for skilled individuals without the requirement for a formal bachelor's degree.

read more
Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

The U.S. Food and Drug Administration has approved Amgen Inc.'s Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab), developed by British drug major AstraZeneca's Rare Disease unit Alexion Pharmaceuticals, to treat certain rare diseases. Soliris is a medicine used to treat adults and children with paroxysmal nocturnal haemoglobinuria or PNH...
RTTNews | 173 days ago
Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen, Inc. (AMGN) announced Tuesday positive top-line results from the DAHLIA study, a randomized, double-blind, active-controlled, two-period crossover Phase 3 study evaluating the efficacy and safety of ABP 959, a biosimilar candidate to SOLIRIS (eculizumab), compared with SOLIRIS in adult patients with paroxysmal nocturnal hemoglobinuria (PNH).
RTTNews | 818 days ago
European Markets Seen Opening On A Firm Note

European Markets Seen Opening On A Firm Note

European markets are expected to open on Tuesday on a positive note even as markets focus on the health of the corporate sector and the potential monetary policy trajectory.
RTTNews | 5h 15min ago
Sensex, Nifty Move Higher As Stocks Rise On Bargain Hunting

Sensex, Nifty Move Higher As Stocks Rise On Bargain Hunting

Indian shares are up firmly in positive territory Tuesday morning with traders indulging in some bargain hunting at several counters following recent steep losses. Positive lead from global markets contribute to the buying interest on the Indian bourses.
RTTNews | 5h 24min ago
European Economic News Preview: Eurozone Inflation, Current Account Data Due

European Economic News Preview: Eurozone Inflation, Current Account Data Due

Final inflation and current account data from the euro area and the treasury select committee hearing on the monetary policy report from the UK are the top events due on Tuesday. At 2.00 am ET, foreign trade data is due from Switzerland. The trade surplus is forecast to narrow to CHF 4.25 billion in October from CHF 4.95 billion in September.
RTTNews | 5h 35min ago